ReviewCancers2023

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Monotherapy Compared with Combination Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis.

Thi Thuy Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.